Search results for "antiarrhythmic agent"

showing 10 items of 10 documents

Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study

2018

Background: Among rate-control or rhythm-control strategies, there is conflicting evidence as to which is the best management approach for non-valvular atrial fibrillation (AF) in elderly patients. Design: We performed an ancillary analysis from the ‘Registro Politerapie SIMI’ study, enrolling elderly inpatients from internal medicine and geriatric wards. Methods: We considered patients enrolled from 2008 to 2014 with an AF diagnosis at admission, treated with a rate-control-only or rhythm-control-only strategy. Results: Among 1114 patients, 241 (21.6%) were managed with observation only and 122 (11%) were managed with both the rate- and rhythm-control approaches. Of the remaining 751 patie…

MaleAnti-Arrhythmia Agents/therapeutic useantiarrhythmic agentComorbidityAged; Aged 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Comorbidity; Diabetes Mellitus; Female; Heart Failure; Heart Rate; Hospitalization; Humans; Male; Odds Ratio; Polypharmacy; Prevalence; Geriatrics and Gerontology; Pharmacology (medical)030204 cardiovascular system & hematologyanticoagulant agentDiabetes Mellitus/drug therapy0302 clinical medicineHeart RateAtrial Fibrillation80 and overOdds RatioPrevalencePharmacology (medical)030212 general & internal medicineLS4_4Aged 80 and overantiarrhythmic agent anticoagulant agent antithrombocytic agent calcium channel blocking agent digoxinHeart Rate/drug effectsDiabetes MellituAtrial fibrillationantithrombocytic agentdigoxinHospitalizationAnti-Arrhythmia AgentFemaleAnti-Arrhythmia AgentsHumanmedicine.medical_specialtySocio-culturale-Geriatrics and Gerontology; Pharmacology (medical)03 medical and health sciencesInternal medicineDiabetes mellitusHeart rateantiarrhythmic agent; anticoagulant agent; antithrombocytic agent; calcium channel blocking agent; digoxinmedicineDiabetes MellitusHumansAgedPolypharmacyHeart Failurebusiness.industryAtrial Fibrillation/drug therapyOdds ratiomedicine.diseaseHeart Failure/drug therapyComorbidityConfidence intervalcalcium channel blocking agentHeart failurePolypharmacyAged; Aged 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Comorbidity; Diabetes Mellitus; Female; Heart Failure; Heart Rate; Hospitalization; Humans; Male; Odds Ratio; Polypharmacy; PrevalenceGeriatrics and Gerontologybusiness
researchProduct

Mitochondrial basis of the anti-arrhythmic action of lidocaine and modulation by the n-6 to n-3 PUFA ratio of cardiac phospholipids

2012

The aim of this study was to evaluate the involvement of mitochondria in the mechanism of the anti-arrhythmic lidocaine. Rats were fed with a diet containing either n-6 polyunsaturated fatty acids (PUFAs, SSO group) or an equimolecular mixture of n-3 and n-6 PUFAs (FO group) for 8 weeks. The hearts were perfused according to the working mode using a medium with or without lidocaine 5 μM. They were then subjected to local ischemia (20 min) and reperfusion (30 min). Dietary n-3 PUFAs triggered the expected decrease in the n-6/n-3 PUFA ratio of cardiac phospholipids. Reperfusing the ischemic area favored the incidence of severe arrhythmias. Lidocaine treatment abolished almost completely reper…

Pharmacologychemistry.chemical_classification0303 health sciencesLidocaineLocal anestheticmedicine.drug_classmedicine.medical_treatmentIschemiachemistry.chemical_element030204 cardiovascular system & hematologyCalciumMitochondrionAntiarrhythmic agentPharmacologymedicine.disease03 medical and health sciences0302 clinical medicineAnticonvulsantchemistryAnesthesiamedicinePharmacology (medical)030304 developmental biologyPolyunsaturated fatty acidmedicine.drugFundamental & Clinical Pharmacology
researchProduct

Editorial: Current trends in the treatment of supraventricular tachycardia in pediatric age

2008

In pediatric age supraventricular tachiarrhythmias represent one of the most common cause of admission in cardiology units. Supraventricular arrhythmias may significantly influence the normal growth of a child with significant psycho-social implications. Pediatric cardiologists should be aware about the arrhythmias they face in their clinical practice. Moreover, they should know the possible risks related to specific arrhythmias and use the most efficacious therapeutic strategy with a correct knowledge of antiarrhythmic drugs. In this issue of Current Pharmacological Design the most recent knowledges on pathophysiology, diagnosis and treatment of supraventricular tachyarrhythmias in pediatr…

Antiarrhythmic agentSettore MED/11 - Malattie Dell'Apparato Cardiovascolare
researchProduct

Alteration of Ventricular Fibrillation by Flecainide, Verapamil, and Sotalol

2000

Background—The purpose of this study was to determine whether the myocardial electrophysiological properties are useful for predicting changes in the ventricular fibrillatory pattern. Methods and Results—Thirty-two Langendorff-perfused rabbit hearts were used to record ventricular fibrillatory activity with an epicardial multiple electrode. Under control conditions and after flecainide, verapamil, or d,l-sotalol, the dominant frequency (FrD), type of activation maps, conduction velocity, functional refractory period, and wavelength (WL) of excitation were determined during ventricular fibrillation (VF). Flecainide (1.9±0.3 versus 2.4±0.6 cm, P<0.05) and sotalol (2.1±0.3 versus 2.5±0.5 cm, P…

ElectrophysiologyVentricular fibrillation ; Mapping ; Antiarrhythmic agents ; ElectrophysiologyMapping:CIENCIAS MÉDICAS ::Medicina interna [UNESCO]UNESCO::CIENCIAS MÉDICASAntiarrhythmic agentsVentricular fibrillation:CIENCIAS MÉDICAS [UNESCO]UNESCO::CIENCIAS MÉDICAS ::Medicina interna
researchProduct

Inhibition by Fendiline of the Transient Outward Current in Rat Ventricular Cardiomyocytes

1999

The effects of fendiline on the transient outward current (Ito) were investigated in rat ventricular cardiomyocytes. Extracellularly applied fendiline reduced peak and steady-state current amplitude of Ito; the inactivation of Ito was accelerated by the drug, which reflects onset of block. The described effects were concentration dependent: half-maximal effects were achieved at approximately 3 microM fendiline. Intracellularly applied fendiline (3 microM) did not affect Ito within 5 min. The steady-state current amplitude of Ito was more efficiently suppressed by the drug at 22 +/- 1 degrees C than at 36 +/- 1 degrees C. The recovery of Ito was analyzed by the application of twin depolarizi…

Malemedicine.medical_specialtyPatch-Clamp TechniquesPotassium ChannelsHeart Ventriclesmedicine.medical_treatmentIn Vitro TechniquesAntiarrhythmic agentdigestive systemMembrane PotentialsRats Sprague-DawleyInternal medicinemedicineAnimalsMyocytePharmacologyCardiac transient outward potassium currentBinding SitesFendilineDose-Response Relationship DrugPulse (signal processing)ChemistryTime constantDepolarizationElectric StimulationRatsIon ExchangeElectrophysiologyEndocrinologyFendilineBiophysicsFemaleCalcium ChannelsCardiology and Cardiovascular MedicineJournal of Cardiovascular Pharmacology
researchProduct

PLASMA CONCENTRATION-EFFECT RELATIONSHIP OF THE ANTIARRHYTHMIC AGENT LORCAINIDE

1978

LorcainideChemistrymedicine.medical_treatmentPlasma concentrationmedicinePharmacologyAntiarrhythmic agentmedicine.drug
researchProduct

The Effects of Epinine on Arterial Blood Pressure and Regional Vascular Resistances in Anesthetized Rats

1998

1. We carried out experiments in anesthetized rats to study the hemodynamic effects of intravenous injections of epinine. 2. Epinine (1-320 micrograms/kg) produced a biphasic effect on mean arterial blood pressure (n = 30). At doses lower than 40 micrograms/kg, arterial blood pressure decreased (by as much as 21.5 +/- 3.4%), though at higher doses it increased dose dependently (by as much as 73.2 +/- 14.5%). Epinine also produced bradicardia in a dose-dependent manner (by as much as 26.4 +/- 4.9%). Sulpiride (100 micrograms/kg) suppressed the hypotensive effect of epinine but did not change the hypertensive effect. In the presence of prazosin (1,000 micrograms/kg), arterial blood pressure r…

medicine.medical_specialtymedicine.medical_treatmentHemodynamicsBlood PressureAntiarrhythmic agentUrethaneRenal CirculationHeart RateInternal medicinemedicinePrazosinAnimalsSplanchnic CirculationRats WistarPharmacologybusiness.industryBlood flowRatsDeoxyepinephrinemedicine.anatomical_structureBlood pressureEndocrinologyDopamine AgonistsCirculatory systemVascular resistanceVascular ResistanceSulpiridebusinessAnesthetics Intravenousmedicine.drugGeneral Pharmacology: The Vascular System
researchProduct

Population modelling to describe pharmacokinetics of amiodarone in rats: Relevance of plasma protein and tissue depot binding

2007

The objective of this paper was to characterize the disposition phase of AM in rats, after different high doses and modalities of i.v. administration. Three fitting programs, WINNONLIN, ADAPT II and NONMEM were employed. The two-stage fitting methods led to different results, none of which can adequately explain amiodarone's behaviour, although a great amount of data per subject is available. The non-linear mixed effect modelling approach allows satisfactory estimation of population pharmacokinetic parameters, and their respective variability. The best model to define the AM pharmacokinetic profile is a two-compartment model, with saturable and dynamic plasma protein binding and linear tiss…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentPopulationAmiodaronePharmaceutical SciencePharmacologyAntiarrhythmic agentAmiodaroneModels BiologicalPharmacokineticsInternal medicineBlood plasmaAnimalsMedicineTissue DistributionDosingRats Wistareducationeducation.field_of_studyDose-Response Relationship Drugbusiness.industryBlood ProteinsBlood proteinsRatsNONMEMEndocrinologyArea Under CurveData Interpretation StatisticalInjections IntravenousbusinessAnti-Arrhythmia Agentsmedicine.drugEuropean Journal of Pharmaceutical Sciences
researchProduct

Ultrastructural evidence for protection of the outer hair cells of the inner ear during intense noise exposure by application of the organic calcium …

1999

Outer hair cells could be protected during intense noise exposure by the application of the calcium channel blocker diltiazem given before and after noise treatment. After various experimental approaches, the ultrastructural morphology was analysed for the different animal populations in the basal part of the second turn of the cochlea, which was the most destroyed area after an acute noise trauma caused by a gun shot (sound pressure at the ear drum 156 dB, frequency maximum between 4 and 6 kHz). Compared to untreated control specimens (experimental animal group I), the outer hair cells in the basal part of the second turn of the cochlea were mostly destroyed without any diltiazem applicati…

medicine.medical_specialtyCytoplasmmedicine.drug_classmedicine.medical_treatmentGuinea PigsCalcium channel blockerAntiarrhythmic agentDiltiazemInternal medicinemedicineAnimalsInner earDiltiazemCochleaChemistryCalcium Channel BlockersDisease Models AnimalHair Cells Auditory OuterMicroscopy Electronmedicine.anatomical_structureEndocrinologyOtorhinolaryngologyHearing Loss Noise-InducedEar InnerAcute DiseaseUltrastructureBiophysicsAudiometry Pure-ToneHair cellNoiseNoise (radio)medicine.drugORL; journal for oto-rhino-laryngology and its related specialties
researchProduct

INTESTINAL ABSORPTION KINETICS OF AMIODARONE IN RAT SMALL INTESTINE

1997

Amiodarone is a widely used antiarrhythmic agent with highly variable therapeutic effects. These seem to be related, at least in part, to the pharmacokinetics of the drug and particularly to some features of its gastrointestinal absorption process. The drug exhibits physico-chemical properties highly suitable for diffusion across lipophilic absorbing membranes, but its low aqueous solubility can act as the rate limiting step for absorption, making the process erratic and variable. In order to gain an insight into the intestinal absorption mechanism of the drug and detect possible non-linearities, a series of experiments using a classical rat gut in situ preparation were carried out with thr…

PharmacologyChromatographyChemistrymedicine.medical_treatmentAmiodarone HydrochloridePharmaceutical ScienceGeneral MedicineAbsorption (skin)Antiarrhythmic agentAmiodaroneIntestinal absorptionMembranePulmonary surfactantPharmacokineticsBiochemistrymedicinePharmacology (medical)medicine.drugBiopharmaceutics &amp; Drug Disposition
researchProduct